Medical Licensing (MD/DO) · Independent exam preparation
MCCQE: Clinical Decisions and Canadian Practice Study Guide
Practise urgent treatment, diagnostic interpretation, prevention, consent and patient communication through focused MCCQE concepts, clinical cases and recall drills.
By CertMedbry · Updated 20 October 2026
Practise recognizing dangerous presentations, interpreting discordant tests, choosing appropriate treatment and discussing decisions with patients. Each concept connects a clinical principle to a discriminating cue and an original application. Use these decisions to strengthen reasoning across clinical disciplines and the professional responsibilities of physicians in Canada.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and level does this guide address?
This guide addresses the Medical Council of Canada Qualifying Examination, now called the MCCQE and formerly MCCQE Part I. The MCC describes the assessed level as that expected of a student completing a medical degree and entering supervised practice in Canada. The provider name, Medical Council of Canada, is not itself an examination title. The NAC Examination is a separate assessment and is not the pathway covered here.
Study smarter: A study guide for the MCCQE · Technical report on the 2025 standard-setting exercise for the MCCQE Part I · MCCQE Part I Annual Technical Report 2024
How many questions and how much testing time are documented?
The assessment model implemented beginning in April 2025 contains 230 multiple-choice questions in two sections of 115. Twenty are pilot or pretest questions that do not contribute to the total score, leaving 210 scored questions. Each section allows up to 2 hours 40 minutes, totaling 5 hours 20 minutes of answering time, with an optional break before the second section. These are the documented April 2025 specifications; they do not independently confirm every operational detail for an October 2026 appointment.
Technical report on the 2025 standard-setting exercise for the MCCQE Part I
What delivery method, adaptivity and item styles are established?
The 2025 report describes a computer-delivered MCQ examination. It states that the separate Clinical Decision-Making component, previously using short-menu and written responses, was removed. The 2024 report documents fixed examination forms replacing an earlier semi-adaptive design and describes test-centre and remote-proctored delivery in English and French. Those delivery details are historical; current appointment availability and any later adaptivity changes are not established here. The four-option questions in this guide are independent learning drills.
Technical report on the 2025 standard-setting exercise for the MCCQE Part I · MCCQE Part I Annual Technical Report 2024
How do the two blueprint categories apply?
Dimensions of Care targets are Health Promotion & Illness Prevention 20±5%, Acute 35±5%, Chronic 30±5% and Psychosocial Aspects 15±5%. Physician Activities targets are Assessment/Diagnosis 45±5%, Management 35±5%, Communication 10±5% and Professional Behaviours 10±5%. These are intersecting classifications, each totaling 100%; they must not be added together. A question can therefore address both Acute and Management. The blueprint was approved in 2014, content specifications in 2016, and the revised assessment model began in April 2025.
Technical report on the 2025 standard-setting exercise for the MCCQE Part I · MCCQE Part I Annual Technical Report 2024
What is the full content scope and which dates are verified?
The official MCC Examination Objectives at https://mcc.ca/objectives/ define the full content scope. The official study guide, published April 1, 2026, connects those objectives to the blueprint and seven CanMEDS roles. It describes medicine, surgery, pediatrics, psychiatry, obstetrics and gynecology, and population health/ethical/legal/organizational medicine as represented approximately equally. Its discipline lists are not exhaustive, and objectives overlap disciplines. A small selective learning set need not assign identical counts to each discipline. No exact effective date for the complete current objectives is established here.
How is this selective guide distributed across the blueprint?
The 60 concepts address 12 prevention, 21 acute, 18 chronic and 9 psychosocial decisions. A concept's domain label uses one blueprint axis, and its application identifies both the care dimension and physician activity. All eight official domain labels are represented. The questions and flashcards each contain 4 prevention, 7 acute, 6 chronic and 3 psychosocial entries. Questions map to 8 Assessment/Diagnosis, 7 Management, 3 Communication and 2 Professional Behaviours activities; flashcards map to 9 Assessment/Diagnosis, 7 Management, 2 Communication and 2 Professional Behaviours activities. These numerical distributions do not demonstrate representative discipline coverage. The coverage map identifies selected objectives and areas requiring further study.
Technical report on the 2025 standard-setting exercise for the MCCQE Part I · Study smarter: A study guide for the MCCQE
What passing standard is supported?
The October 2025 standard-setting report documents an approved pass score of 439 on a reporting scale of 300–600, implemented beginning with the April 2025 examination. This is a scaled score, not a percentage-correct requirement. The examination is criterion-referenced: performance is compared with the established standard. The historical 2024 score scale and passing score should not be substituted for the revised model. Results on these learning questions do not predict an examination outcome.
Technical report on the 2025 standard-setting exercise for the MCCQE Part I
Does passing the MCCQE grant a medical licence?
Passing is one component of Canadian medical licensing pathways and an eligibility criterion for the Licentiate of the Medical Council of Canada. Provincial and territorial medical regulatory authorities determine registration requirements. The examination also serves residency-entry and some practice-ready assessment pathways; these uses do not make them separate variants of the MCCQE or establish independent-practice authorization.
Technical report on the 2025 standard-setting exercise for the MCCQE Part I
How should Canadian and international clinical references be applied?
Clinical references support the specific decisions taught here; the MCC blueprint establishes assessment scope rather than treatment recommendations. Canadian guidance is used where available. International specialty guidance supports selected clinical mechanisms and scenarios. Ontario confidentiality examples are explicitly jurisdiction-specific and must be interpreted under Ontario requirements; other provinces and territories have their own applicable laws and regulatory policies.
Study smarter: A study guide for the MCCQE · CPSO: Protecting Personal Health Information
These independent educational materials support preparation for the MCCQE, formerly MCCQE Part I. The official MCC Examination Objectives at https://mcc.ca/objectives/ define the full scope. This 60-concept guide is selective and does not replace the official outline or imply MCC endorsement. Matching care-dimension proportions does not establish representative coverage of disciplines or objectives.
Outline used: The workbook label names the provider; it is mapped here to the Medical Council of Canada Qualifying Examination (MCCQE), formerly MCCQE Part I. MCC documents blueprint approval in 2014, content-specification approval in 2016, and implementation of a revised assessment model in April 2025. The official MCC study guide, published April 1, 2026, confirms the examination name and its basis in the MCC blueprint and Examination Objectives. No exact effective date for the complete current objectives is established by the supplied issuer evidence. The 2024 technical report is historical supporting documentation.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Health Promotion & Illness Prevention20±5%
1.When should routine folic acid supplementation begin?
Folate supports early embryonic development, including neural tube closure, which occurs before many pregnancies are recognized. Routine advice for people who could become pregnant is a daily multivitamin containing 0.4 mg of folic acid, ideally begun at least three months before pregnancy. The decision is therefore linked to pregnancy possibility rather than a positive pregnancy test. A balanced diet remains valuable, but dietary folate alone does not replace the recommended supplement.
Apply it
Health Promotion & Illness Prevention; Management: A patient plans to stop contraception in four months and asks whether prenatal vitamins can wait. Recommend beginning a daily multivitamin containing 0.4 mg folic acid now, before conception occurs.
Common pitfall: Waiting until the first prenatal visit misses part of the protective window. Routine supplementation advice also should not be extrapolated automatically to individualized higher-risk dosing.
Folic acid, healthy pregnancy and neural tube defect prevention
2.How should indicated MMR vaccination be timed around pregnancy?
MMR is a live attenuated vaccine and is generally contraindicated during pregnancy because of theoretical fetal risk. A pregnant patient lacking indicated protection should have postpartum vaccination arranged rather than receive routine antenatal MMR. This prospective precaution differs from counselling after inadvertent exposure: MMR exposure alone is not an indication for pregnancy termination. Reviewing vaccination history helps identify opportunities to update protection before or after pregnancy.
Apply it
Health Promotion & Illness Prevention; Management: A pregnant patient is found to lack rubella immunity. Explain why routine MMR is deferred during pregnancy and place a clear postpartum vaccination plan in the record for follow-through.
Common pitfall: Treating every vaccine as contraindicated during pregnancy confuses live-vaccine precautions with recommendations for non-live products. A contraindication to planned administration also does not establish fetal injury after inadvertent exposure.
Immunization in pregnancy and breastfeeding: Canadian Immunization Guide
3.How should community naloxone access be paired with overdose education?
Naloxone can temporarily reverse an opioid overdose, but access to a kit must be paired with recognition and response skills. Teach people likely to witness an overdose to recognize unresponsiveness and slow or absent breathing, call emergency services, administer naloxone and follow resuscitation instructions. Continued emergency care is necessary because respiratory depression can recur after naloxone wears off. A community prevention intervention therefore combines access, practical education and connection to emergency care.
Apply it
Health Promotion & Illness Prevention; Management: A community service provides take-home naloxone to people at risk of witnessing an overdose. Include a demonstration and an explanation of calling emergency services, supporting breathing and staying with the person until help arrives.
Common pitfall: Providing a kit without response education leaves critical actions unclear. Awakening after naloxone does not justify cancelling emergency care or leaving the person alone.
4.Why is Tdap recommended during each pregnancy?
Maternal Tdap stimulates pertussis antibodies that cross the placenta and provide passive protection during early infancy, before the infant's own immunization series provides adequate protection. Canadian guidance recommends vaccination during every pregnancy, ideally between 27 and 32 weeks. A previous adult dose does not replace this pregnancy-specific strategy because the goal includes maximizing antibody available for transfer to the current fetus. Maternal vaccination complements, rather than substitutes for, the infant's routine immunizations.
Apply it
Health Promotion & Illness Prevention; Management: At 29 weeks, a patient reports receiving Tdap before a previous pregnancy. Recommend Tdap in the current pregnancy and explain that transferred maternal antibodies help protect this newborn early in life.
Common pitfall: Using the usual adult booster interval overlooks the infant-protection purpose. Vaccinating only after delivery also misses the opportunity for antenatal placental antibody transfer.
5.How does reducing access to lethal means support suicide prevention?
Suicide prevention includes asking directly about access to potentially lethal methods and arranging concrete steps to reduce that access. Explore medications, firearms and other methods relevant to the person's circumstances. Collaboratively identify who can remove or secure dangerous items and how the plan will be implemented. This environmental intervention complements assessment, coping strategies and access to support. It does not replace emergency evaluation when current suicidal intent or imminent danger is present.
Apply it
Health Promotion & Illness Prevention; Management: Following an assessment without current imminent intent, a patient identifies readily accessible medications as a potential method. Agree on a specific arrangement for a trusted support person to secure them and clarify how necessary medication will remain available safely.
Common pitfall: A general instruction to be careful does not establish a means-safety plan. A stated intention to secure dangerous items also cannot neutralize current intent requiring emergency assessment.
NIMH: Adult Outpatient Brief Suicide Safety Assessment Guide
6.What does antenatal HBsAg screening identify?
Hepatitis B surface antigen identifies current hepatitis B infection and helps determine whether newborn prophylaxis must be arranged. Canadian guidance recommends HBsAg screening during each pregnancy unless immunity or carrier status is already established. The clinical purpose is not merely documenting a vaccination history: maternal infection can require a coordinated plan at birth. Distinguish HBsAg, an infection marker, from antibodies used to assess immunity when interpreting records and planning prevention.
Apply it
Health Promotion & Illness Prevention; Assessment/Diagnosis: A patient begins prenatal care without documented hepatitis B status. Arrange appropriate HBsAg screening and ensure a positive result triggers communication with the team responsible for newborn prophylaxis at delivery.
Common pitfall: A recollection of previous vaccination is not the same as established immune status. Ordering an immunity marker alone can miss the question of current infection.
Immunization in pregnancy and breastfeeding: Canadian Immunization Guide
8.How is diagnostic specificity calculated?
Specificity is the proportion of people without the condition who receive a negative test result: true negatives divided by true negatives plus false positives. It describes correct classification within the disease-free group. High specificity limits false-positive findings, but does not by itself establish that a positive result is likely to represent disease. That latter question requires positive predictive value and depends on how common disease is in the tested population.
Apply it
Health Promotion & Illness Prevention; Assessment/Diagnosis: Among 500 participants without disease, 475 test negative and 25 test positive. Specificity is 475 divided by 500, or 95%; the 25 positive results represent false positives in the disease-free group.
Common pitfall: Using all negative results as the denominator calculates negative predictive value. Specificity alone cannot tell a patient the probability that their positive result is correct.
9.What does positive predictive value tell a patient?
Positive predictive value is the proportion of positive test results that are true positives: true positives divided by true positives plus false positives. It answers the patient-facing question of how often a positive result corresponds to the condition in the tested population. The denominator therefore includes only positive results. A test can have good sensitivity and specificity yet a modest positive predictive value when applied to a population in which the condition is uncommon.
Apply it
Health Promotion & Illness Prevention; Assessment/Diagnosis: A program reports 45 true-positive and 105 false-positive results. Positive predictive value is 45 divided by 150, or 30%; most positive screens therefore require clarification rather than immediate disease labelling.
Common pitfall: Quoting sensitivity as the chance that a positive result is correct reverses the conditional probability. Keep the reference group explicit before choosing the denominator.
10.How is negative predictive value interpreted?
Negative predictive value is the proportion of negative test results that are true negatives: true negatives divided by true negatives plus false negatives, or TN/(TN+FN). It describes how often a negative result corresponds to absence of the condition in the tested population. Unlike sensitivity, its denominator is defined by the test result rather than actual disease status. A reassuring negative result becomes less reassuring when disease is more prevalent, assuming sensitivity and specificity remain unchanged.
Apply it
Health Promotion & Illness Prevention; Assessment/Diagnosis: A study has 760 true-negative results and 40 false-negative results. Calculate negative predictive value as 760 divided by 800, or 95%, and explain that 5% of negative results occurred in affected participants.
Common pitfall: A high negative predictive value in a low-prevalence screening population cannot automatically be transferred to a symptomatic population with a substantially higher probability of disease.
Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff | FDA · Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers | FDA
11.Why does disease prevalence change predictive values?
Predictive values depend on how many affected and unaffected people enter testing. With unchanged sensitivity and specificity, lower prevalence produces fewer true positives relative to false positives, lowering positive predictive value. Higher prevalence increases the proportion of negative results that may be false negatives, lowering negative predictive value. This is why the same test result can carry different implications in population screening and a highly selected symptomatic clinic. Always identify the population before interpreting reassurance or alarm.
Apply it
Health Promotion & Illness Prevention; Assessment/Diagnosis: Two clinics use the same test, but one evaluates referred patients with typical symptoms. Expect its positive predictive value to be higher than in a low-prevalence screening population, assuming comparable test performance.
Common pitfall: Predictive values are not fixed properties that travel unchanged between settings. Avoid interpreting a screening brochure's predictive value as an individualized probability for every patient.
Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers | FDA
Acute35±5%
14.Which findings favour vasovagal syncope after vaccination?
Vasovagal syncope commonly produces pallor, clamminess and bradycardia around an injection, with improvement when the patient lies supine. These findings contrast with anaphylaxis accompanied by airway swelling, wheezing, generalized allergic findings or persistent circulatory compromise. Timing alone does not distinguish the conditions because either can follow vaccination promptly. Assess the whole pattern and continue observing recovery; a label of fainting should not override evolving respiratory or cardiovascular evidence of a systemic allergic reaction.
Apply it
Acute; Assessment/Diagnosis: Immediately after an injection, a patient becomes pale and briefly loses consciousness with a slow pulse. They recover promptly supine without wheeze or hives. The pattern favours vasovagal syncope, while continued assessment confirms sustained recovery.
Common pitfall: Assuming every collapse after vaccination is anaphylaxis ignores discriminating physiology. Equally, attributing persistent hypotension or respiratory symptoms to anxiety can delay necessary emergency treatment.
15.How do postoperative adhesions cause bowel obstruction?
Adhesions following abdominal surgery can tether or kink small bowel, impairing passage of intestinal contents. Colicky abdominal pain, vomiting, distension and obstipation support mechanical obstruction, particularly with a relevant surgical history. Previous surgery increases suspicion but does not prove that adhesions are the cause. CT can identify the obstruction pattern, assess alternative explanations and reveal features such as a closed loop or ischemia that change the urgency of management.
Apply it
Acute; Assessment/Diagnosis: A patient with previous laparotomy develops cramping pain, repeated vomiting, abdominal distension and inability to pass flatus. Consider adhesive small bowel obstruction and obtain appropriate imaging to evaluate the cause and identify threatened bowel.
Common pitfall: Treating postoperative history as a complete diagnosis can miss another cause of obstruction. Passing some stool early also does not reliably exclude a developing obstruction.
Bologna guidelines for diagnosis and management of adhesive small bowel obstruction: 2017 update
17.What is the treatment foundation for typical bronchiolitis?
Bronchiolitis is usually a clinical diagnosis in an infant with a viral prodrome followed by lower-airway symptoms and increased work of breathing. Care centres on adequate hydration, gentle nasal suction when useful and respiratory support when indicated. Routine bronchodilators do not reliably improve the important outcomes of typical bronchiolitis. Assess feeding, hydration, oxygenation and respiratory effort to determine support needs rather than treating wheeze alone as proof of reversible bronchospasm.
Apply it
Acute; Management: A young infant has coryza, diffuse wheeze, crackles and reduced feeding. Assess hydration and respiratory status, support feeds or fluids as needed, and use appropriate oxygen or respiratory support rather than automatically prescribing salbutamol.
Common pitfall: Wheezing does not make an infant's illness asthma. Routine bronchodilator treatment can distract from the feeding failure and respiratory effort that determine bronchiolitis care needs.
Bronchiolitis: Recommendations for diagnosis, monitoring and management
18.When are investigations unnecessary in bronchiolitis?
A typical, uncomplicated bronchiolitis presentation usually does not require routine chest radiography or broad laboratory testing. Radiographs may show nonspecific changes that encourage an unsupported bacterial diagnosis and unnecessary antibiotics. Testing becomes more useful when the clinical pattern, severity or course suggests another diagnosis or complication. The decision should follow the question a test can answer, rather than the presence of wheeze, crackles or a respiratory virus alone.
Apply it
Acute; Assessment/Diagnosis: An otherwise healthy infant has a typical first bronchiolitis episode without focal findings or an unexpected course. Diagnose clinically and monitor support needs rather than ordering a chest radiograph simply to document the illness.
Common pitfall: Routine imaging can create diagnostic confusion through nonspecific findings. Avoid the opposite extreme of refusing investigations when atypical features or deterioration suggest an alternative explanation.
Bronchiolitis: Recommendations for diagnosis, monitoring and management
19.Why must early pregnancy pain prompt assessment of location?
Ectopic pregnancy is implantation outside the uterine cavity, most often within a fallopian tube. Early pregnancy pain or bleeding requires assessment that establishes pregnancy location rather than assuming miscarriage or normal intrauterine pregnancy. Transvaginal ultrasound and pregnancy-hormone assessment help guide evaluation, but an initially unlocated pregnancy may require follow-up. Hemodynamic instability or features suggesting internal bleeding demand urgent escalation; a single symptom pattern or isolated hormone result cannot establish a safe location.
Apply it
Acute; Assessment/Diagnosis: A patient with a positive pregnancy test has unilateral pelvic pain and spotting. Assess stability and arrange appropriate transvaginal imaging and hormone evaluation; do not call the bleeding a completed miscarriage before pregnancy location is clarified.
Common pitfall: A positive pregnancy test confirms pregnancy-related hormone production, not intrauterine implantation. A nondiagnostic early scan also does not independently exclude ectopic pregnancy or establish miscarriage.
21.Why are brain and vascular imaging urgent in suspected stroke?
Sudden focal neurologic deficits require rapid imaging to distinguish hemorrhage from ischemia and identify vascular occlusion that may be amenable to reperfusion treatment. Immediate brain and vascular imaging are particularly important when reperfusion is possible. Establishing last known well, assessing deficits and checking glucose occur within the urgent stroke pathway rather than as reasons to postpone imaging. Clinical appearance alone cannot safely distinguish hemorrhagic from ischemic stroke or define large-vessel anatomy.
Apply it
Acute; Management: A patient develops sudden aphasia and unilateral weakness and arrives soon afterward. Activate the stroke pathway, establish last known well and obtain immediate brain and vascular imaging while completing parallel bedside assessment and glucose measurement.
Common pitfall: Starting treatment intended for ischemic stroke before excluding hemorrhage can be harmful. An improving deficit also should not automatically terminate urgent assessment for a vascular event.
Canadian Stroke Best Practices: Emergency Department Evaluation and Management
22.Why is bedside glucose essential during stroke assessment?
Hypoglycemia can cause altered consciousness and focal neurologic findings that resemble stroke. Immediate glucose measurement identifies a reversible contributor that requires prompt correction. A low value does not justify ignoring persistent focal deficits after correction, because hypoglycemia and cerebrovascular disease can coexist. The useful sequence is to identify and treat the metabolic abnormality rapidly while maintaining the urgent neurologic assessment appropriate to the remaining clinical picture and treatment opportunities.
Apply it
Acute; Assessment/Diagnosis: A patient with diabetes presents with weakness and speech difficulty. Bedside testing reveals hypoglycemia. Correct it immediately, reassess the deficits and continue urgent stroke evaluation if focal abnormalities remain rather than assuming the entire presentation is explained.
Common pitfall: Waiting for routine laboratory processing delays a readily identifiable reversible cause. Conversely, finding hypoglycemia should not end assessment when focal neurologic abnormalities persist after correction.
Canadian Stroke Best Practices: Emergency Department Evaluation and Management
24.Which cognitive changes suggest delirium?
A sudden change in attention, orientation or thinking should prompt urgent assessment for delirium and its underlying cause. Confusion may include difficulty following conversation, disorientation or hallucinations, and symptoms can vary over time. The abrupt change from baseline is a major discriminating cue, including in a patient who already has dementia. Treat new confusion as a potential manifestation of acute illness rather than assuming it is an expected consequence of age or chronic cognitive impairment.
Apply it
Acute; Assessment/Diagnosis: A previously conversational older adult becomes inattentive and disoriented over one day and describes seeing unfamiliar people. Obtain collateral information about baseline function and arrange urgent medical assessment for the new cognitive change.
Common pitfall: Labelling sudden confusion as dementia progression can miss a treatable acute cause. A temporarily lucid interval does not exclude delirium or eliminate the need for assessment.
25.What does intravenous calcium accomplish in hyperkalemia?
Hyperkalemia can disrupt myocardial electrical activity and produce dangerous conduction abnormalities. Intravenous calcium is used when indicated to counter the adverse cardiac effects and protect cardiac excitability. It does not lower the serum potassium concentration or remove potassium from the body. Treatment therefore requires separate consideration of myocardial protection, temporary intracellular shifting and actual elimination, with cardiac and biochemical reassessment. Understanding these distinct aims prevents apparent ECG improvement from being mistaken for resolution of the potassium excess.
Apply it
Acute; Management: A patient has marked hyperkalemia with new ECG changes. Give indicated intravenous calcium for cardiac protection while arranging therapies that lower circulating potassium and remove the excess, with continued monitoring of the clinical and biochemical response.
Common pitfall: A better ECG after calcium does not mean potassium has normalized. Calcium must not become the sole intervention when the potassium burden remains dangerously elevated.
UK Kidney Association: Management of Hyperkalaemia in Adults, July 2026
26.How does insulin temporarily lower circulating potassium?
Insulin promotes movement of potassium from extracellular fluid into cells, reducing the measured serum concentration without reducing total body potassium. Glucose is used as appropriate to limit treatment-related hypoglycemia, and blood glucose requires monitoring after treatment. Because redistribution is temporary, potassium can rise again if the excess is not eliminated. The clinical plan must therefore pair the immediate shift with reassessment and a suitable removal strategy rather than declaring treatment complete after one improved result.
Apply it
Acute; Management: After insulin-based treatment, a patient's potassium falls into a safer range. Continue glucose monitoring and repeat potassium assessment while addressing elimination, explaining that the initial improvement reflects redistribution rather than removal of the excess.
Common pitfall: An initially normal glucose does not eliminate later hypoglycemia risk after insulin. A lower potassium result also does not prove that total body potassium has decreased.
UK Kidney Association: Management of Hyperkalaemia in Adults, July 2026
27.When does hyperkalemia require urgent dialysis in a patient receiving hemodialysis?
Cardiac protection and intracellular redistribution leave excess total body potassium in place. UK Kidney Association guidance recommends urgent dialysis for a patient receiving hemodialysis whose potassium is at least 6.5 mmol/L. If dialysis is delayed, temporary medical potassium-lowering treatment is still needed. Indicated intravenous calcium remains necessary for cardiac protection even when dialysis is available. This dialysis threshold applies to the specified hemodialysis population; it is not a universal dialysis rule for every patient with hyperkalemia.
Apply it
Acute; Management: A maintenance-hemodialysis patient presents with potassium 6.8 mmol/L and new hyperkalemic ECG changes. Arrange urgent dialysis and give indicated intravenous calcium. If dialysis cannot begin promptly, administer temporary potassium-shifting treatment with glucose and potassium monitoring while dialysis is organized.
Common pitfall: An improved potassium result after redistribution does not remove the need for definitive elimination in this scenario. Do not omit cardiac protection while awaiting dialysis or generalize this threshold to every clinical population.
UK Kidney Association: Management of Hyperkalaemia in Adults, July 2026
28.Why are corticosteroids useful across croup severity levels?
Croup produces upper-airway inflammation, typically causing a barking cough, hoarseness and inspiratory stridor. Corticosteroids reduce airway inflammation and improve outcomes across mild through severe presentations. Their role is not confined to children who already need nebulized epinephrine. Assess severity through work of breathing, stridor at rest and overall condition, while keeping the child calm. A typical mild presentation still offers an opportunity for effective anti-inflammatory treatment rather than observation alone.
Apply it
Acute; Management: A child has a barking cough and hoarse voice but no stridor at rest or marked distress. Treat typical croup with a corticosteroid and provide clear advice about worsening work of breathing or other concerning changes.
Common pitfall: Reserving corticosteroids for severe stridor misses their benefit in milder croup. Antibiotics do not address the usual inflammatory viral process in an otherwise typical presentation.
Canadian Paediatric Society: Acute management of croup in the emergency department
29.Why is observation needed after nebulized epinephrine for croup?
Nebulized epinephrine rapidly reduces upper-airway obstruction in croup, but its benefit wanes after approximately two hours. A child who improves immediately may therefore develop recurrent symptoms before the illness is controlled. Canadian pediatric guidance supports observation for 2–4 hours after treatment, with discharge only when improvement is sustained without recurrence. Corticosteroids address inflammation over a longer interval, so the two treatments serve complementary purposes rather than making post-treatment observation unnecessary.
Apply it
Acute; Management: A child with stridor at rest improves after nebulized epinephrine and a corticosteroid. Continue observation for 2–4 hours after epinephrine and base discharge on sustained improvement, rather than the appearance immediately after nebulization.
Common pitfall: Rapid improvement is a treatment response, not proof of durable recovery. Discharge before the temporary effect wanes can miss recurrent clinically important upper-airway obstruction.
Canadian Paediatric Society: Acute management of croup in the emergency department
30.Which airway findings argue against uncomplicated croup?
Drooling, dysphagia and a toxic appearance are warning signs for alternative serious upper-airway disease rather than uncomplicated croup. Their significance lies in the possibility of a threatened airway that requires urgent experienced assessment. A barking cough should not override these concerning features when they coexist. Avoid distressing the child unnecessarily and escalate airway support appropriately; attempting to force a routine examination can worsen obstruction in a patient whose airway is already precarious.
Apply it
Acute; Assessment/Diagnosis: A febrile child has stridor, drooling and difficulty swallowing and appears very ill. Seek urgent expert airway assessment and keep the child calm instead of treating the presentation as routine croup based on stridor alone.
Common pitfall: Stridor identifies upper-airway obstruction, not its cause. Repeatedly examining or upsetting a child with dangerous airway features can increase distress without resolving the diagnostic uncertainty.
Canadian Paediatric Society: Acute management of croup in the emergency department
31.How should unconscious hypoglycemia be treated?
Severe hypoglycemia is defined by impaired function requiring assistance, rather than by a glucose threshold alone. An unconscious adult cannot safely take oral carbohydrate. Give intravenous glucose when intravenous access is available; otherwise use intramuscular or subcutaneous glucagon and activate emergency help. Airway protection and repeated glucose assessment remain important while consciousness recovers. Once the immediate episode is treated, identify the precipitant and ongoing risk rather than assuming a single correction guarantees sustained recovery.
Apply it
Acute; Management: An adult using insulin is unconscious with confirmed hypoglycemia and has working intravenous access. Give intravenous glucose and monitor response. Keep oral food and drink withheld until consciousness and safe swallowing have recovered.
Common pitfall: Putting juice or sugar into an unconscious patient's mouth creates aspiration risk. A very low glucose value is important, but functional impairment determines whether assistance is required.
32.How does pulse status guide opioid resuscitation?
Opioid toxicity can cause life-threatening hypoventilation before cardiac arrest. A trained clinician who identifies a definite pulse with inadequate breathing provides assisted breaths or bag-mask ventilation while emergency help and naloxone are arranged. Suspected cardiac arrest requires CPR; naloxone must not delay ventilation or chest compressions. Because naloxone can wear off before the opioid does, initial awakening does not establish lasting safety. Reassess breathing and arrange continued emergency observation and care.
Apply it
Acute; Management: A trained clinician finds an unresponsive person with a definite pulse and very slow breathing after opioid exposure. Activate emergency help, provide assisted ventilation and give naloxone without interrupting respiratory support, then monitor for recurrent depression.
Common pitfall: Waiting for naloxone to work leaves hypoventilation untreated. Conversely, the definite-pulse scenario should not be confused with suspected cardiac arrest, which requires prompt CPR.
2025 AHA Guidelines: Adult and Pediatric Special Circumstances of Resuscitation · Health Canada: Opioid overdose
Chronic30±5%
34.When does an abnormal diabetes test require confirmation?
Diabetes Canada diagnostic thresholds include fasting plasma glucose at least 7.0 mmol/L and HbA1c at least 6.5% when HbA1c is appropriate for the patient. In an asymptomatic adult, a qualifying abnormal laboratory result requires confirmation rather than immediate diagnosis from one isolated value. Symptoms and unequivocal hyperglycemia change that context. Use laboratory diagnostic testing and consider factors that may distort HbA1c before deciding that a threshold has established persistent diabetes.
Apply it
Chronic; Assessment/Diagnosis: An asymptomatic adult has a laboratory fasting plasma glucose of 7.2 mmol/L on an initial test. Arrange confirmatory testing instead of assigning a definitive diagnosis solely from this single result without corroborating evidence.
Common pitfall: A diagnostic threshold is not a licence to ignore confirmation in an asymptomatic person. Capillary monitoring and laboratory diagnostic testing also serve different purposes.
Diabetes Canada: Definition, Classification and Diagnosis of Diabetes
35.Why can hemolysis make HbA1c falsely reassuring?
HbA1c reflects glucose exposure over the circulating life of erythrocytes. Shortened erythrocyte survival, as in hemolysis or recovery after blood loss, reduces the time available for glycation and can falsely lower HbA1c regardless of assay method. A result that conflicts with repeated glucose measurements should therefore prompt consideration of erythrocyte turnover rather than immediate dismissal of the glucose data. Choose an assessment strategy that remains interpretable in the patient's hematologic context.
Apply it
Chronic; Assessment/Diagnosis: A patient with active hemolysis has repeated elevated glucose measurements but a near-normal HbA1c. Recognize shortened erythrocyte survival as a reason for the discrepancy and use interpretable glucose-based assessment rather than assuming normal average glycemia.
Common pitfall: Not every HbA1c discrepancy is laboratory error or inaccurate home monitoring. Repeating the same assay does not correct bias caused by shortened erythrocyte survival.
36.What spirometry finding confirms COPD airflow obstruction?
COPD diagnosis requires an appropriate clinical context and persistent airflow obstruction demonstrated after bronchodilator administration. The Canadian Thoracic Society uses a post-bronchodilator FEV1/FVC ratio below 0.70 in its diagnostic framework. Symptoms or smoking exposure alone do not establish obstruction. Distinguish the ratio used to identify obstruction from FEV1 percentage predicted, which helps characterize its severity after obstruction has been demonstrated. This prevents symptom labels from replacing objective confirmation.
Apply it
Chronic; Assessment/Diagnosis: A patient with chronic exertional dyspnea and substantial smoke exposure has a post-bronchodilator FEV1/FVC ratio of 0.62. Interpret this as persistent obstruction in the clinical context, then characterize symptoms, exacerbations and spirometric severity separately.
Common pitfall: A reduced FEV1 percentage predicted alone does not establish the obstructive pattern. Pre-bronchodilator symptoms and measurements should not be substituted for persistent post-bronchodilator obstruction.
2023 Canadian Thoracic Society Guideline on Pharmacotherapy in Stable COPD
37.What explains persistent hypocalcemia after thyroid surgery?
The parathyroid glands lie beside the thyroid and regulate calcium. Thyroid surgery can disrupt their function, causing hypocalcemia. Most postoperative dysfunction resolves, but persistent loss of parathyroid function can require long-term calcium and vitamin D treatment. Perioral or fingertip tingling and muscle spasms are clinically relevant symptoms. Ongoing follow-up should assess symptoms, calcium status and replacement needs rather than treating these complaints as an inevitable consequence of the neck incision.
Apply it
Chronic; Management: Months after thyroid surgery, a patient with documented persistent parathyroid dysfunction reports recurrent tingling around the mouth. Arrange prompt calcium assessment and review calcium and vitamin D treatment with the treating team; muscle spasms or worsening symptoms require urgent assessment.
Common pitfall: Tingling after thyroid surgery can reflect a biochemical complication. Conversely, early temporary parathyroid dysfunction does not establish that lifelong replacement will necessarily be required.
38.Which maintenance treatment fits the CTS mild COPD profile?
The 2023 CTS recommendation supports LAMA or LABA monotherapy for persistent mild symptoms when CAT is below 10, mMRC is 1, FEV1 is at least 80% predicted, and there has been at most one moderate exacerbation without an emergency visit or admission in the preceding year. This is a defined clinical profile rather than a recommendation for every patient called mild. Confirm symptom burden and exacerbation history before selecting the initial maintenance approach.
Apply it
Chronic; Management: A patient with confirmed COPD has CAT 7, mMRC 1, FEV1 85% predicted and no exacerbations in the preceding year. For persistent symptoms, select a LAMA or LABA as initial maintenance therapy within the CTS profile.
Common pitfall: Applying monotherapy solely because FEV1 is preserved ignores symptoms and exacerbations. The recommendation's eligibility conditions matter; a different profile may justify a different maintenance approach.
2023 Canadian Thoracic Society Guideline on Pharmacotherapy in Stable COPD
39.When do kidney abnormalities qualify as chronic kidney disease?
CKD requires abnormalities of kidney structure or function present for at least three months and carrying implications for health. A single reduced estimated GFR does not establish chronicity and may reflect an acute process. Previous results, repeated measurements and other evidence help establish duration. Once chronicity is supported, classify kidney disease using its cause, GFR category and albuminuria category rather than using one creatinine result as a complete diagnosis or risk description.
Apply it
Chronic; Assessment/Diagnosis: A patient has an eGFR of 48 mL/min/1.73 m² during a new illness and no previous measurements. Investigate the current abnormality and seek prior evidence rather than immediately labelling it chronic kidney disease.
Common pitfall: Waiting three months should not mean ignoring a potentially acute kidney problem. Chronicity is a classification requirement, not a reason to postpone assessment of a new abnormality.
KDIGO 2024 Clinical Practice Guideline for Evaluation and Management of CKD
41.Why do G1 and G2 values not establish CKD alone?
G1 and G2 describe relatively preserved estimated filtration, but these categories alone do not establish CKD without evidence of kidney damage. Persistent albuminuria or relevant structural abnormalities can establish kidney disease despite preserved GFR. Conversely, an isolated G2 value without a damage marker should not automatically become a CKD diagnosis. Assess both filtration and kidney damage and establish chronicity; neither a reassuring GFR nor a category label answers the entire diagnostic question.
Apply it
Chronic; Assessment/Diagnosis: One patient has eGFR 78 with no damage markers; another has eGFR 95 with persistent significant albuminuria. Avoid diagnosing CKD from the first GFR alone, and recognize that preserved filtration does not exclude disease in the second.
Common pitfall: Equating a normal creatinine with absence of kidney disease misses albuminuric disease. Equating every G2 measurement with CKD creates an unsupported diagnosis without damage evidence.
KDIGO 2024 Clinical Practice Guideline for Evaluation and Management of CKD
42.Which thyroid results support overt primary hypothyroidism?
In primary hypothyroidism, the thyroid gland produces insufficient hormone and the pituitary responds by increasing TSH. An elevated TSH together with reduced free T4 therefore supports overt primary hypothyroidism. The paired pattern is more informative than nonspecific symptoms such as fatigue or constipation alone. An elevated TSH with normal free T4 is a different biochemical pattern and should not be described as overt hormone deficiency without considering its specific context.
Apply it
Chronic; Assessment/Diagnosis: A patient reports fatigue, cold intolerance and constipation. Testing shows elevated TSH and low free T4. Interpret the combination as supporting overt primary hypothyroidism rather than diagnosing solely from symptoms shared by many conditions.
Common pitfall: TSH should be interpreted with the clinical context and free T4 when needed. Calling every elevated TSH overt hypothyroidism ignores the distinction between biochemical patterns.
43.Why can a normal TSH miss central hypothyroidism?
TSH is useful when the pituitary-thyroid feedback system is intact. In pituitary or hypothalamic dysfunction, TSH may be low or inappropriately normal despite reduced free T4 because the expected compensatory rise does not occur. A normal TSH therefore cannot independently exclude thyroid hormone deficiency in a patient with relevant pituitary disease. The discriminating clue is low free T4 with a TSH that is not appropriately elevated, interpreted alongside the broader endocrine context.
Apply it
Chronic; Assessment/Diagnosis: A patient with known pituitary disease has fatigue, low free T4 and a TSH within the reference interval. Recognize an inappropriately normal TSH and assess central hypothyroidism rather than declaring thyroid function normal.
Common pitfall: A laboratory flag is not a substitute for feedback physiology. TSH within its reference interval can still be inappropriate when free T4 is reduced.
44.How should levothyroxine be separated from calcium and iron?
Calcium and iron supplements can reduce levothyroxine absorption when taken too close to it. Separate either supplement from levothyroxine by at least four hours. ATA advice also supports taking levothyroxine consistently on an empty stomach and waiting one hour before food or drink other than water. When thyroid results worsen after a supplement is added, correct administration timing before assuming the dose requirement has increased, and reassess thyroid biochemistry after approximately 6–8 weeks of the consistent regimen.
Apply it
Chronic; Management: A previously stable patient takes levothyroxine and iron together at breakfast. Agree on levothyroxine with water at 07:00, breakfast at 08:00 and iron at noon; calcium, if prescribed, must also remain at least four hours from levothyroxine. Repeat thyroid tests after approximately 6–8 weeks.
Common pitfall: Increasing levothyroxine without identifying an absorption interaction can cause overtreatment when the supplement is later stopped or rescheduled. Ask explicitly about nonprescription calcium, iron and multivitamins.
Thyroid Hormone Treatment | American Thyroid Association · Post Operative Expectations | American Thyroid Association · American Thyroid Association: Adult Hypothyroidism
46.How should oral iron be started and monitored in a stable adult with iron deficiency anemia?
Oral iron is usually appropriate when absorption is adequate and correction is not urgent. A BSG example is ferrous sulfate 200 mg, providing 65 mg elemental iron, once daily fasting. Verify the product's elemental content: formulation strength is not the elemental-iron dose. For gastrointestinal intolerance, consider one tablet every other day, an alternative oral preparation or intravenous iron. Measure hemoglobin within four weeks; a rise of at least 10 g/L after two weeks of daily treatment supports response. Generally continue replacement for approximately three months after hemoglobin normalizes to replenish iron stores.
Apply it
Chronic; Management: A hemoglobin increase from 98 to 110 g/L after two weeks supports continuing treatment. An increase from 98 to 100 g/L warrants reviewing adherence, elemental dose, ongoing bleeding, malabsorption and concurrent deficiencies. Consider intravenous iron when oral treatment is ineffective, contraindicated, intolerable or unlikely to work.
Common pitfall: The two-week benchmark applies to daily treatment; alternate-day dosing is better assessed at approximately four weeks. Improvement does not identify the cause of iron loss, and normal hemoglobin does not establish replenished stores.
British Society of Gastroenterology guidelines for management of iron deficiency anaemia in adults
47.Why can inflammation conceal iron deficiency on ferritin testing?
Ferritin reflects iron stores but also rises as an acute-phase reactant. A low ferritin strongly supports depleted stores, whereas a normal or elevated value can be misleading when inflammation is present. Interpret ferritin alongside the clinical setting and other iron indices, such as transferrin saturation, when iron deficiency remains plausible. This distinction prevents a value within the laboratory interval from prematurely closing investigation of anemia in a patient with chronic inflammatory disease.
Apply it
Chronic; Assessment/Diagnosis: A patient with active inflammatory disease has anemia and a ferritin within the reference interval. Assess additional iron indices and the clinical context instead of excluding iron deficiency solely because ferritin is not reduced.
Common pitfall: The same ferritin value can mean different things with and without inflammation. A normal result does not always establish adequate usable iron or exclude depleted stores.
British Society of Gastroenterology guidelines for management of iron deficiency anaemia in adults
48.Which patients with new iron deficiency anemia generally need upper and lower gastrointestinal investigation?
Newly diagnosed unexplained iron deficiency anemia in an adult man or postmenopausal woman warrants investigation for gastrointestinal pathology, including potentially important occult bleeding. The BSG guideline generally recommends gastroscopy and colonoscopy as first-line gastrointestinal investigations in this group, with suitable alternatives when colonoscopy is unsuitable. Initial assessment also includes screening for coeliac disease and a history addressing gastrointestinal symptoms, visible bleeding, medications associated with bleeding, blood donation and other losses. This is a clinical pathway from BSG guidance; UK referral arrangements are not Canadian rules.
Apply it
Chronic; Assessment/Diagnosis: A 68-year-old postmenopausal woman has newly confirmed iron deficiency anemia without an established source. Begin iron replacement, review bleeding and medication history, screen for coeliac disease and arrange upper and lower gastrointestinal investigation through the applicable local pathway, even if she reports no visible gastrointestinal bleeding.
Common pitfall: Absence of visible bleeding does not exclude occult gastrointestinal loss. A rise in hemoglobin with iron replacement confirms treatment response but does not remove the need to investigate the unexplained deficiency.
British Society of Gastroenterology guidelines for management of iron deficiency anaemia in adults
51.How should depressive symptoms be evaluated alongside chronic medical illness?
Chronic medical illness does not make persistent anhedonia, depressed mood or functional decline diagnostically unimportant. Assess the depressive symptom pattern and suicide risk while reviewing medical conditions and medications that can cause similar symptoms. Thyroid disorders are one example of a medical mimic. Depression can also coexist with physical disease, so finding a medical contributor does not automatically explain every symptom. Duration, core mood symptoms and changes in functioning help distinguish a depressive syndrome from isolated fatigue.
Apply it
Chronic; Assessment/Diagnosis: A patient with longstanding physical illness develops several weeks of loss of pleasure, low mood and impaired daily functioning. Assess depression and safety, review medicines and relevant medical contributors, and avoid attributing the entire change to the pre-existing physical diagnosis.
Common pitfall: Fatigue alone does not establish depression. Conversely, a chronic medical diagnosis should not prevent assessment of a coexisting, potentially treatable depressive disorder.
Psychosocial Aspects15±5%
52.When does suicidal thinking require immediate emergency assessment?
Current suicidal thoughts with intent or an imminent plan require immediate safety measures and emergency mental health assessment. Do not leave the patient alone while arranging the appropriate response. Ask directly about current thoughts, intent, plan and access to means; direct questions clarify danger rather than creating it. A reassuring manner or willingness to attend a future appointment does not override evidence of immediate risk. Disposition follows current safety needs, not a promise alone.
Apply it
Psychosocial Aspects; Management: A patient reports intending to act on a suicide plan today and has access to the means. Maintain observation and a safe environment while arranging emergency assessment rather than sending the patient home for routine follow-up.
Common pitfall: A verbal promise to remain safe cannot neutralize current intent. Avoid substituting a future appointment or a checklist score for action on an immediate threat.
NIMH: Adult Outpatient Brief Suicide Safety Assessment Guide
53.What makes a suicide safety plan actionable?
A collaborative safety plan identifies warning signs, practical coping actions, supportive people, professional contacts and steps to reduce access to lethal means. Its value comes from concrete actions the patient can use during a crisis, rather than a general promise not to attempt suicide. Match planning to the current risk assessment and involve supportive people appropriately. A safety plan supports care but does not replace emergency assessment when current intent or other imminent danger is present.
Apply it
Psychosocial Aspects; Management: After assessment finds no immediate suicidal intent, work with the patient to list personal warning signs, two coping actions, trusted contacts, crisis resources and a specific means-safety step, then check that the plan is usable.
Common pitfall: A safety contract can create false reassurance without changing practical access to help. Even a detailed safety plan does not justify outpatient care when immediate danger requires escalation.
NIMH: Adult Outpatient Brief Suicide Safety Assessment Guide
54.Why is previous suicidal behaviour important to assessment?
Previous suicidal behaviour is a major predictor of future attempts and should be explored explicitly rather than inferred from the current mood or the patient's initial disclosure. Ask about what happened, intent, timing, method and the care received, alongside current thoughts and access to means. Past behaviour informs risk formulation, but it does not replace assessment of present danger. A patient without previous attempts may still require emergency intervention for current intent.
Apply it
Psychosocial Aspects; Assessment/Diagnosis: A patient initially reports only low mood but later describes a previous suicide attempt. Explore that history carefully and integrate it with current thoughts, intent and supports rather than treating the disclosure as unrelated background.
Common pitfall: No previous attempt does not mean no current risk. Conversely, past behaviour alone should not replace a current individualized assessment of intent, circumstances and immediate safety.
NIMH: Adult Outpatient Brief Suicide Safety Assessment Guide
56.How does capacity affect adolescent confidentiality in Ontario?
Ontario confidentiality decisions depend on the patient's capacity to consent to the collection, use or disclosure of personal health information, not simply their age or a parent's request. A capable minor's wishes about disclosure must be respected, subject to applicable legal exceptions. Treatment consent and information-disclosure consent are related but distinct decisions. Discuss confidentiality clearly and obtain appropriate permission before sharing information; do not assume that parental involvement automatically authorizes access to every part of the record.
Apply it
Psychosocial Aspects; Professional Behaviours: In Ontario, a capable adolescent requests confidential care and a parent later asks for details. Assess disclosure authority and the adolescent's consent rather than releasing information solely because the requester is a parent.
Common pitfall: A parental relationship does not automatically override a capable minor's confidentiality. Avoid promising absolute secrecy because specific legal exceptions can still require or authorize disclosure.
57.Which features warrant assessment for a depressive episode?
Persistent depressed mood or loss of interest or pleasure, accompanied by other symptoms and functional impairment, warrants clinical assessment for depression. A major depressive episode generally involves symptoms present most of the day, nearly every day, for at least two weeks, with depressed mood or anhedonia among the core features. Assess sleep, appetite, energy, concentration and suicidal thinking, while considering medical contributors and previous elevated mood episodes that could change diagnostic interpretation.
Apply it
Psychosocial Aspects; Assessment/Diagnosis: A patient reports three weeks of pervasive loss of interest, poor sleep, low energy and impaired work function. Assess the full depressive syndrome, safety and mood history rather than attributing the presentation to ordinary transient sadness.
Common pitfall: Duration alone does not establish a depressive disorder without the symptom pattern and impact. A depression assessment also remains incomplete if current suicidal thinking is not explored.
58.How does decreased sleep need distinguish mania from insomnia?
During mania, reduced need for sleep accompanies increased energy or activity and an unusually elevated or irritable mood. The person may sleep very little yet feel rested, unlike someone with insomnia who wants sleep and feels tired. Other clues include accelerated speech, racing thoughts and risky behaviour. Evaluate the cluster, change from baseline and functional consequences rather than diagnosing from short sleep alone. Severe impairment or psychotic features heighten concern for a manic episode.
Apply it
Psychosocial Aspects; Assessment/Diagnosis: A patient sleeps three hours nightly yet feels unusually energetic, speaks rapidly and makes major impulsive purchases. Assess an elevated-mood episode rather than treating the sleep change as isolated insomnia without exploring mood and function.
Common pitfall: Short sleep is not specific to mania. The discriminating cue is reduced need for sleep within an episodic change in energy, mood, activity and behaviour.
59.How should financial barriers change a care discussion?
A medically appropriate plan may fail when the patient cannot afford medicines, testing supplies or related care. Ask about feasibility in a neutral way, identify the specific barrier and develop a realistic plan collaboratively. This is part of patient-centred communication and health advocacy, rather than evidence of indifference or unwillingness. The MCC study guide explicitly maps inability to afford diabetes medicines and testing supplies to communication within psychosocial care, illustrating how social determinants change clinical implementation.
Apply it
Psychosocial Aspects; Communication: A patient has stopped glucose testing because supplies compete with rent. Ask which costs are unaffordable, discuss feasible alternatives and available assistance, and agree on a workable monitoring plan rather than repeating the original instructions.
Common pitfall: Labelling the patient nonadherent before asking about cost can obscure the actual problem. Simplifying instructions alone does not solve a material inability to obtain treatment.
60.Why does a manic history change depression treatment planning?
A history of mania changes the interpretation of a current depressive presentation because bipolar disorder includes episodes of depression as well as elevated mood states. Antidepressant monotherapy can precipitate mania or rapid cycling in susceptible patients, so the treatment approach must account for the longitudinal mood history. Ask about periods of reduced sleep need, increased energy, unusually elevated or irritable mood and consequential behaviour before treating a depressive episode as unipolar depression.
Apply it
Psychosocial Aspects; Management: A patient requesting an antidepressant describes a previous episode of minimal sleep, excessive energy and serious impulsive spending. Reassess the mood diagnosis and plan bipolar-appropriate treatment rather than automatically beginning antidepressant monotherapy.
Common pitfall: Current low mood does not erase earlier mania. Screening only for present depressive symptoms can lead to a treatment choice that destabilizes the broader mood disorder.
Assessment/Diagnosis45±5%
7.How is diagnostic sensitivity calculated?
Sensitivity is the proportion of people who truly have a condition who receive a positive test result: true positives divided by true positives plus false negatives. Its denominator is everyone with the condition, not everyone with a positive result. High sensitivity reduces the proportion of affected people missed, but a negative result still requires interpretation in light of disease probability and the test's performance. Constructing the disease-status columns first prevents denominator errors.
Apply it
Health Promotion & Illness Prevention; Assessment/Diagnosis: A screening study includes 80 affected participants; 72 test positive and eight test negative. Calculate sensitivity as 72 divided by 80, or 90%, and identify the eight missed cases as false negatives.
Common pitfall: Dividing true positives by all positive results calculates positive predictive value. A highly sensitive test also does not guarantee that every negative result excludes disease.
20.Which intermittent symptoms suggest intussusception?
Intussusception occurs when one segment of bowel telescopes into another, producing obstruction and potentially compromising blood supply. Recurrent episodes of marked distress with pallor, vomiting or unexplained lethargy in a young child are important cues, even if the child appears well between episodes. Bloody stools are late and inconsistent, so their absence should not delay investigation. Ultrasound is the first diagnostic study when the presentation raises suspicion for this condition.
Apply it
Acute; Assessment/Diagnosis: An infant repeatedly cries intensely, becomes pale and then appears comfortable. Vomiting and episodic lethargy develop without bloody stool. Arrange ultrasound for suspected intussusception instead of waiting for a classic stool finding to appear.
Common pitfall: Reassurance based on normal intervals between attacks overlooks the episodic nature of obstruction. Waiting for a complete classic triad delays recognition of potentially threatened bowel.
Royal Children's Hospital Melbourne: Clinical Practice Guidelines—Intussusception
33.How can ketoacidosis occur without marked hyperglycemia?
Ketoacidosis reflects ketone accumulation and metabolic acidosis, so marked hyperglycemia is not essential to recognition. Euglycemic presentations can occur, including in people taking an SGLT2 inhibitor. Assess symptoms, acid-base status and ketones rather than excluding the diagnosis because glucose is only modestly elevated. Urine ketone testing does not adequately represent beta-hydroxybutyrate, a major ketone in DKA, so a negative urine result cannot independently exclude ketoacidosis when the clinical and biochemical pattern is concerning.
Apply it
Acute; Assessment/Diagnosis: A patient taking an SGLT2 inhibitor develops vomiting, abdominal discomfort and rapid breathing with modest glucose elevation. Investigate acid-base status and blood ketones despite a negative urine ketone result rather than dismissing ketoacidosis.
Common pitfall: Using glucose alone as the gatekeeper misses euglycemic ketoacidosis. A urine ketone result must not override evidence of acidosis and a compatible clinical presentation.
40.How are GFR and albuminuria combined in CKD classification?
KDIGO classification combines cause, GFR category and albuminuria category because filtration and urinary albumin provide different information about kidney disease and prognosis. G3a denotes eGFR 45–59 mL/min/1.73 m². Albuminuria categories use urine albumin-to-creatinine ratio, with A2 representing moderately increased albuminuria, approximately 3–30 mg/mmol. A patient with established chronicity can therefore be described as G3a A2. Always check the reported units before applying albuminuria thresholds.
Apply it
Chronic; Assessment/Diagnosis: Over six months, a patient's eGFR remains 52 mL/min/1.73 m² and urine ACR is 12 mg/mmol. Classify the established kidney disease as G3a A2, while separately evaluating and documenting its underlying cause.
Common pitfall: Confusing mg/mmol with mg/g can produce a major category error. A GFR category alone also leaves out albuminuria information that materially changes risk assessment.
KDIGO 2024 Clinical Practice Guideline for Evaluation and Management of CKD
Management35±5%
13.When does a post-vaccination reaction require epinephrine?
Rapid respiratory compromise or circulatory impairment after vaccination should raise concern for anaphylaxis, especially with generalized urticaria or swelling. Intramuscular epinephrine is the immediate first-line treatment because it addresses airway, breathing and cardiovascular effects of the systemic reaction. Emergency assistance and supportive care proceed alongside treatment. Antihistamines may improve skin symptoms but do not replace epinephrine for dangerous respiratory or circulatory involvement. Do not wait for every possible feature to develop.
Apply it
Acute; Management: Minutes after vaccination, a patient develops generalized hives, wheezing and hypotension. Give intramuscular epinephrine promptly, activate emergency assistance and support airway and circulation while monitoring the response to treatment and the need for additional care.
Common pitfall: Choosing an antihistamine first because hives are visible delays treatment of life-threatening physiology. Skin improvement does not establish that respiratory or circulatory danger has resolved.
16.Which obstruction findings require urgent surgical escalation?
A trial of nonoperative care for adhesive small bowel obstruction is inappropriate when there is evidence of peritonitis, strangulation or bowel ischemia. A closed loop can trap a segment at two points, threatening its blood supply and increasing urgency. Clinical deterioration and CT evidence of compromised bowel therefore outweigh an otherwise plausible adhesive explanation. The key decision is whether bowel remains viable, rather than whether the patient has a familiar risk factor for uncomplicated obstruction.
Apply it
Acute; Management: A patient with obstruction develops guarding, worsening continuous pain and CT evidence of a closed loop with concern for ischemia. Escalate urgently to surgery instead of continuing an uncomplicated-obstruction observation plan.
Common pitfall: A previous episode that resolved without surgery does not establish that the present episode is safe to observe. New peritoneal or ischemic findings change management.
Bologna guidelines for diagnosis and management of adhesive small bowel obstruction: 2017 update
23.When should swallowing be assessed after acute stroke?
Acute stroke can impair swallowing and airway protection, creating aspiration risk even when a patient is awake and requests water. Keep the patient without oral food, fluid or medication until an appropriate swallowing screen has been completed. Alertness and a conversational voice do not establish safe swallowing. The precaution applies to tablets as well as meals, so medication planning must account for the swallowing result and the available safe route.
Apply it
Acute; Management: An alert patient undergoing stroke evaluation asks for water and oral tablets. Explain the aspiration concern, withhold oral intake and arrange the swallowing screen before using the oral route for fluids, food or medication.
Common pitfall: A small sip is still oral intake and can expose an unrecognized swallowing impairment. Family reassurance that the patient usually swallows well does not establish current safety.
Canadian Stroke Best Practices: Emergency Department Evaluation and Management
45.When should thyroid tests be repeated after a replacement change?
In a nonpregnant adult, thyroid blood tests are generally reassessed approximately 6–8 weeks after starting levothyroxine or changing the dose. This interval allows the biochemical response to the new regimen to be assessed before another adjustment. An early result may not reflect the eventual response and can encourage unnecessary repeated changes. Review administration consistency and interacting medicines alongside laboratory results so that a dose decision addresses the actual treatment exposure.
Apply it
Chronic; Management: A nonpregnant adult starts levothyroxine and requests a dose increase after several days because fatigue persists. Explain the monitoring interval and arrange repeat thyroid testing in approximately 6–8 weeks, while reviewing administration and relevant symptoms.
Common pitfall: Rapid serial dose changes can respond to incomplete biochemical equilibration. The routine nonpregnant interval should not be applied indiscriminately to pregnancy or other situations requiring individualized monitoring.
Communication10±5%
12.How does teach-back establish understanding?
Teach-back asks the patient to explain information in their own words, revealing whether the clinician's explanation has been understood. It is more informative than asking whether the patient understands, which can produce agreement despite uncertainty. Use a neutral invitation, clarify any misunderstanding, and check again. In consent discussions, teach-back can explore the proposed intervention, material risks and alternatives, while remaining distinct from a full assessment of decision-making capacity.
Apply it
Health Promotion & Illness Prevention; Communication: After discussing a procedure, ask, 'To check that I explained this clearly, how would you describe the main benefits, risks and alternatives?' Correct a misunderstanding and invite the patient to explain the revised understanding.
Common pitfall: Turning teach-back into a memory examination can shame patients and obstruct disclosure. Its purpose is to improve explanation, not reward repetition of medical terminology.
55.How does LIVES guide first-line support after partner violence?
WHO's LIVES approach emphasizes listening, inquiring about needs and concerns, validating the person's experience, enhancing safety and supporting access to help. Speak privately, avoid blame and respect the survivor's choices. A disclosure is not permission to contact a partner or impose a specific life decision. Assess immediate danger and offer practical support in a way that preserves autonomy. The initial response should make further disclosure and safety planning easier rather than requiring the patient to justify the experience.
Apply it
Psychosocial Aspects; Communication: A patient privately discloses partner violence but is not ready to leave. Validate the disclosure, ask about immediate safety and priorities, and discuss support options without contacting the partner or making continued care conditional on leaving.
Common pitfall: Pressuring a survivor to leave immediately can undermine trust and overlook safety realities. Joint discussion with the abusive partner can compromise privacy and increase danger.
Professional Behaviours10±5%
49.How should a capable adult's informed refusal be handled?
A capable adult may voluntarily refuse recommended treatment, even when the refusal carries substantial risk. Explore the patient's reasons, explain material consequences and alternatives, confirm understanding and appreciation, and document the discussion. The clinician's disagreement does not itself establish incapacity. Continue offering appropriate care and opportunities for discussion rather than treating refusal as abandonment of the relationship. The essential distinction is between an informed autonomous choice and a decision impaired by inability to understand or appreciate.
Apply it
Chronic; Professional Behaviours: A capable adult declines a recommended intervention after accurately explaining its benefits, alternatives and consequences of refusal. Respect the decision, document the discussion and agree on ongoing care and opportunities to revisit the choice.
Common pitfall: A high-risk refusal does not automatically permit treatment without consent. A signed refusal form also cannot replace a meaningful discussion of understanding, alternatives and consequences.
50.What abilities determine treatment decision-making capacity?
Treatment capacity concerns the ability to understand information relevant to a particular decision and appreciate the reasonably foreseeable consequences of accepting or declining it. It is decision-specific and may change over time. Assess these abilities through discussion rather than using agreement with the clinician as a proxy. If capacity is lacking, follow the applicable legal framework for substitute decision-making; relatives do not automatically displace a capable patient's choice simply because the decision is difficult.
Apply it
Chronic; Professional Behaviours: A patient can repeat treatment facts but insists the described consequences cannot apply to them despite clear evidence. Explore appreciation directly and assess capacity for this decision instead of relying on factual repetition alone.
Common pitfall: Orientation questions and a cognitive score do not independently establish treatment capacity. Understanding facts and appreciating their personal consequences are related but distinct abilities requiring assessment.
CMPA: Consent—A guide for Canadian physicians · CMPA Good practices: Informed consent
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Distinguish immediate stabilization from definitive treatment: epinephrine for anaphylaxis, ventilation in opioid toxicity, and cardiac protection versus potassium elimination.
- Interpret results through physiology: glucose versus HbA1c, free T4 versus TSH, and filtration versus albuminuria.
- Medicine coverage: selected hyperglycemia, hypoglycemia, stroke, potassium, kidney, respiratory, thyroid and anemia decisions. Extend study to cardiovascular prevention, chest pain, hypertension and other official objectives.
- Obstetrics and gynecology coverage: preconception folate, maternal immunization, antenatal hepatitis B screening and early pregnancy location. Extend study to contraception, obstetric hypertension, labour, postpartum care and abnormal uterine bleeding.
- Pediatrics coverage: bronchiolitis, croup, dangerous stridor alternatives and intussusception. Extend study to newborn assessment, development, growth and the well child.
- Surgery coverage: postoperative adhesive obstruction, threatened bowel, postoperative parathyroid dysfunction and gastrointestinal investigation of unexplained iron deficiency. Extend study to trauma, hernias, breast presentations and perioperative assessment.
- Psychiatry coverage: depression, medical mimics, mania, bipolar treatment hazards, delirium and suicide assessment. Extend study to anxiety, psychosis, eating disorders and substance withdrawal.
- PHELO coverage: diagnostic-test interpretation, community overdose prevention, lethal-means safety, consent, Ontario confidentiality, violence support and financial barriers. Extend study to outbreak management, population health programs, Indigenous health and organizational responsibilities.
- Use the official MCC Examination Objectives as the full scope. The discipline map is overlapping and selective; numerical blueprint proportions do not establish comprehensive coverage.
A practical preparation plan
1. Map the full objectives
Build a study map from the official MCC Examination Objectives. Assign each objective a care dimension and physician activity, and check representation across medicine, surgery, pediatrics, psychiatry, obstetrics and gynecology, and PHELO.
2. Explain the decision before reviewing it
For each concept, state the mechanism, decisive finding and next action from memory. Then compare your explanation with the answer and identify the particular boundary described in the pitfall.
3. Interleave competing presentations
Study pairs that require discrimination: anaphylaxis versus vasovagal syncope, croup versus dangerous airway disease, primary versus central hypothyroidism, and elevated glucose versus misleading HbA1c.
4. Review every option
Complete the independent questions and explain why each alternative is less appropriate. Record whether an error arose from missed cues, incorrect physiology, a denominator mistake or an unsafe sequencing decision.
5. Revisit weak decisions and expand breadth
Use spaced flashcard practice for mechanisms and criteria. Revisit difficult decisions sooner, then apply them to a different age, setting or comorbidity. Continue expanding into official objectives absent from this selective guide.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Technical report on the 2025 standard-setting exercise for the MCCQE Part I
- MCCQE Part I Annual Technical Report 2024
- Study smarter: A study guide for the MCCQE
- Folic acid, healthy pregnancy and neural tube defect prevention
- Immunization in pregnancy and breastfeeding: Canadian Immunization Guide
- Pertussis vaccines: Canadian Immunization Guide
- Principles of Epidemiology: Lesson 5, Appendix A
- CMPA Good practices: Informed consent
- Anaphylaxis and other acute reactions following vaccination
- Diabetes Canada: Hyperglycemic Emergencies in Adults
- Bronchiolitis: Recommendations for diagnosis, monitoring and management
- RCOG: Ectopic pregnancy
- Canadian Stroke Best Practices: Emergency Department Evaluation and Management
- NHS: Sudden confusion (delirium)
- UK Kidney Association: Management of Hyperkalaemia in Adults, July 2026
- Diabetes Canada: Definition, Classification and Diagnosis of Diabetes
- 2023 Canadian Thoracic Society Guideline on Pharmacotherapy in Stable COPD
- KDIGO 2024 Clinical Practice Guideline for Evaluation and Management of CKD
- American Thyroid Association: Adult Hypothyroidism
- British Society of Gastroenterology guidelines for management of iron deficiency anaemia in adults
- CMPA: Consent—A guide for Canadian physicians
- NIMH: Adult Outpatient Brief Suicide Safety Assessment Guide
- WHO: Health workers—Listening when women need it most
- CPSO: Protecting Personal Health Information
- Canadian Paediatric Society: Acute management of croup in the emergency department
- Diabetes Canada: Hypoglycemia
- Health Canada: Opioid overdose
- NGSP: Factors that Interfere with HbA1c Test Results
- NIMH: Depression
- NIMH: Bipolar Disorder
- 2025 AHA Guidelines: Adult and Pediatric Special Circumstances of Resuscitation
- Bologna guidelines for diagnosis and management of adhesive small bowel obstruction: 2017 update
- Royal Children's Hospital Melbourne: Clinical Practice Guidelines—Intussusception
- Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff | FDA
- Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers | FDA
- Thyroid Hormone Treatment | American Thyroid Association
- Post Operative Expectations | American Thyroid Association
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.